KROS
Keros Therapeutics Inc
11.60$
-0.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -75.0% | +704.0% | -0.5% | -99.2% | +2,251.0% | +6,775.0% | |
| – | +71.6% | -96.5% | +48.4% | +79.8% | -49.5% | +50.8% | +22.8% | |
| – | – | – | – | -108.0% | – | +2,251.0% | +6,732.5% | |
| – | +71.9% | +94.8% | +62.9% | +58.3% | +55.0% | +28.4% | -25.3% | |
| – | +101.5% | +301.9% | +66.7% | +29.0% | +26.6% | +17.0% | +15.0% | |
| – | +76.7% | +130.2% | +66.1% | +50.1% | +48.2% | +26.0% | -19.8% | |
| – | – | – | – | – | – | – | – | |
| – | +33.3% | -25.0% | -33.3% | -75.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -96.9% | -2,250.0% | – | -100.0% | -20,700.0% | – | +1,527.7% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.